The Chemours (CC) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CC The Chemours

Watchlist

14.950
0.0000.00%

Close Feb 28 16:00 ET

14.960
+0.010+0.07%

Post 20:01 ET

2.23BMarket Cap26.23P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

The Chemours To Go Ex-Dividend On February 28th, 2025 With 0.25 USD Dividend Per Share
Moomoo NewsFeb 26 20:00 ET
Chemours Price Target Cut to $19.00/Share From $23.00 by Barclays
Dow JonesFeb 24 09:16 ET · Ratings
Chemours Is Maintained at Equal-Weight by Barclays
Dow JonesFeb 24 09:16 ET · Ratings
Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $19
Moomoo NewsFeb 24 03:32 ET · Ratings
A Quick Look at Today's Ratings for The Chemours(CC.US), With a Forecast Between $19 to $27
Moomoo NewsFeb 20 08:00 ET · Ratings
Titanium Dioxide - Global Strategic Business Report 2025-2030 Featuring Analysis of 16 Major Companies, Including Evonik Industries, Huntsman Corporation, The Chemours Company & More
Yahoo FinanceFeb 20 07:47 ET

Comments

SpyderCall

Jun 5, 2024 16:57

This turned out to be a great short, so far.

$The Chemours (CC.US)$
$SPDR S&P 500 ETF (SPY.US)$

SpyderCall: Options Action in This Ticker was Skewed Heavily on the Bearish Side Today

SpyderCall

May 29, 2024 22:00

Options Action in This Ticker was Skewed Heavily on the Bearish Side Today

$The Chemours (CC.US)$
Unusual Options Activity
There was an unusual amount of activity on the options chain for The Chemours company. Most of the activity was on the put side. You can see this in the heavily skewed put to call ratio in the picture directly below. A lopsided put/call ratio like this doesn't show the full picture. We need to find out if the puts were bought or sold to know if the activity was bullish or bear...

Dow tops 40,000 for the first time: Will the U.S. market rally march on?

Movers and Shakers

Mar 28, 2024 07:32

Columns Today's Morning Movers and Top Ratings: EL, BAC, ALL, RH and More

Morning Movers
Gapping up
$Estee Lauder (EL.US)$ Shares soared over 3% following an upgrade to buy from neutral by Bank of America, which referenced the company's profitability recovery efforts, new products, and growing market share in the prestige beauty sector.
$Allstate (ALL.US)$ The insurance stock climbed 0.9% after HSBC raised its rating to buy from hold, with analyst Vikram Gandhi commending the company's "decisive management...

Moomoo AI

Mar 27, 2024 18:02

The revelation of material weaknesses in Chemours' financial reporting and the manipulation of vendor payments and receivables by top executives could negatively impact investor confidence and the company's stock price.

Chemours Finds Material Weaknesses After Internal Review, Stock Slumps ~11% After Hours

Moomoo AI

Mar 27, 2024 16:49

Chemours' ongoing investigation and executive suspension could hurt investor confidence and stock price, despite a narrower Q4 loss and higher revenue.